Eligibility and safety of the first interferon‐free therapy against hepatitis C in a real‐world setting

E-ISSN： 1478-3231|35|7|1845-1852

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.7, 2015-07, pp. : 1845-1852

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon‐free antiviral treatment of chronic hepatitis C in the transplant setting

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 9, 2015-09 ,pp. : 1011-1024

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety of interferon‐free therapies for chronic hepatitis C: a network meta‐analysis

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 41, Iss. 5, 2016-10 ,pp. : 478-485

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interferon‐free, direct‐acting antiviral therapy for chronic hepatitis C

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 1352-0504, Iss. 11, 2015-11 ,pp. : 861-870

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interferon‐free, direct‐acting antiviral therapy for chronic hepatitis C

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 11, 2015-11 ,pp. : 861-870

John Wiley & Sons Inc

Access to resources Recommend Favorite

The case for cost‐effectively treating cryoglobulinemic vasculitis with interferon‐free anti–hepatitis C virus therapy

HEPATOLOGY, Vol. 62, Iss. 3, 2015-09 ,pp. : 975-975

John Wiley & Sons Inc

Access to resources Recommend Favorite